The threat of Medicare clamping down on drug ...
Frederic Guerard, head of Novartis’ ophthal...
With Novartis’ acquisition of Encore Vision...
Ophthalmology CEO turned VC Abbie Celniker, n...
On February 28, the National Eye Institute wi...
Consolidation is coming to ophthalmology. Las...